Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receiving immune checkpoint inhibition
2021 · Thrombosis Update · 5 citations
https://doi.org/10.1016/j.tru.2021.100056
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
178
Citations
7
h-index
6
i10-index
Birgitte Bjørnhart is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Lung Cancer Research Studies. The author has an h-index of 7, co-authored 17 publications.
ORCID: 0000-0002-1331-061Xhttps://doi.org/10.1016/j.tru.2021.100056
https://doi.org/10.6084/m9.figshare.23830976
Click to start Chat